A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/1992
11/30/1992	WO1992021359A1 Antineoplastic chemotherapeutic of plant origin, having high selectivity and greatly reduced toxicity, and process for the preparation thereof
11/26/1992	WO1992020356A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
11/26/1992	WO1992020330A1 New thermoplastic polymeric material and process for making same
11/26/1992	WO1992020329A1 Enzyme systems
11/26/1992	DE4216355A1 Verfahren zur bereitstellung von antigen-spezifischen b- und t-lymphozyten sowie davon erhaltene monoklonale antikoerper A method of providing antigen-specific B- and T-lymphocytes obtained therefrom as well as monoclonal antibodies
11/26/1992	CA2109622A1 New thermoplastic polymeric material and process for making same
11/26/1992	CA2102607A1 Enzyme systems
11/25/1992	EP0514603A1 Viral mediated destruction of neoplastic cells
11/24/1992	US5165938 Topical treatment with cells
11/24/1992	US5165932 Therapeutical compositions against psoriasis
11/24/1992	US5165931 Peptifluorin and neopeptifluorin
11/19/1992	EP0513120A1 Device for detecting vibratory disturbances in living human organs or tissue
11/19/1992	EP0389583B1 Preparation and use of a physiologically active polypeptide for treating aids
11/18/1992	CN1066272A Process for preparation of anti-thrombin polypeptides
11/18/1992	CN1066188A Prepn. method for tonic oral liquor
11/18/1992	CN1066187A Softening process for pilose antler slice
11/17/1992	WO1992020783A1 Process for preparing antigen-specific b and t lymphocytes and monoclonal antibodies obtained therefrom
11/17/1992	WO1992020695A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
11/17/1992	WO1992020372A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	US5164377 Sulphated glycosaminoglycuronan with antithrombotic activity
11/17/1992	US5164183 Growth promoter for bifidobacterium species and method of using the same
11/17/1992	CA2109315A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	CA2087157A1 Process for preparing antigen-specific b and t lymphocytes and monoclonal antibodies obtained therefrom
11/17/1992	CA1310444C Cck8 derived peptides, their preparation, and pharmaceutical compositions containing them
11/17/1992	CA1310266C Thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
11/15/1992	WO1992020373A1 Heteroconjugate antibodies for treatment of hiv infection
11/15/1992	CA2102511A1 Heteroconjugate antibodies for treatment of hiv infection
11/12/1992	WO1992019355A1 Methods for processing red blood cell products for long term storage free of microorganisms
11/12/1992	WO1992019280A1 Antivenom immunesera
11/12/1992	WO1992019268A1 New hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
11/12/1992	WO1992019195A1 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/12/1992	WO1992015276A3 Therapeutic and cosmetic compositions for treatment of skin
11/12/1992	DE4212132A1 Propolisbestandteile enthaltendes feststoffprodukt, seine herstellung und verwendung Propolis-containing solid product, its production and use
11/11/1992	EP0512883A1 Concentrate of blood coagulation factor XI with high specific activity, appropriate for therapeutic use and its process of preparation
11/11/1992	EP0512857A2 Composition comprising bacterial culture residue and decapsulated bacterial cells and its use
11/11/1992	EP0512102A1 Proteins purified from mammalian gestational tissue which control cell proliferation
11/11/1992	CN1065994A Marrow scavenger and its preparation method
11/04/1992	WO1992019259A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
11/04/1992	EP0511306A1 Tumor killing effects of enterotoxins and related compounds
11/04/1992	EP0511234A1 Stable injectible solutions for factor viii.
11/04/1992	CN1065773A Sterilizing incense for poultry
11/04/1992	CN1018893B Tissue graft composition and preparing method thereof
11/04/1992	CA2108886A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
11/03/1992	US5160490 Three-dimensional cell and tissue culture apparatus
11/03/1992	CA1309676C Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor viii:c
10/1992
10/29/1992	WO1992018137A1 Method for inducing bone formation using an extract of human osteosarcoma cell line saos-2
10/28/1992	EP0510318A1 Compositions for the topical treatment of burns
10/27/1992	US5158975 Use of stearidonic acid
10/27/1992	US5158937 Veterinary medicine
10/27/1992	US5158934 Method of inducing bone growth using TGF-β
10/27/1992	US5158881 Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
10/27/1992	US5158874 Determining metastic potential of tumor cells and isolating metastic tumor cells
10/27/1992	US5157894 Orientation and loading device for vials in general and syringe vials in particular
10/21/1992	EP0509553A1 Anti-lymphotoxin antibody, its production and use
10/21/1992	EP0509041A1 Fibrin sealant delivery method
10/21/1992	EP0457856A4 Isolation growth and differentiation of human muscle cells
10/21/1992	EP0191827B1 Method of removing n-terminal amino acid residues from eucaryotic polypetide analogs and polypeptides produced thereby
10/21/1992	CN1065392A Wide pulse type dc instrument for treatment of myopia
10/20/1992	US5156973 Antiviral blood sampling process and apparatus
10/20/1992	US5156967 Treatment with ion exchange resin
10/20/1992	US5156957 Transformed mammalian cell containing an expression vector which is capable of producing a heterodimeric human fertility hormone coded by a distinct RNA
10/20/1992	US5156844 For controlled delivery of a neurotransmitter to the brain
10/20/1992	CA1309020C Extracorporeal removal of immunoglobulin-g and circulating immune complexes
10/17/1992	WO1992018643A1 The use of pasteurella haemolytica glycoprotease in a process for recovering cells rich in o-glycosylated surface portions
10/17/1992	CA2108565A1 The use of pasteurella haemolytica glycoprotease in a process for recovering cells rich in o-glycosylated surface portions
10/15/1992	WO1992017567A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992	WO1992017505A1 Monoclonal antibodies to stem cell factor receptors
10/15/1992	WO1992017500A1 Novel megakaryocyte amplifying factor and production thereof
10/15/1992	WO1992017498A1 Product and method for improving keratinocyte adhesion to the dermis
10/15/1992	WO1992017165A1 A single dose vaccination system
10/15/1992	DE4111782A1 Strengthening the immune system with propolis resin - dissolved in high strength ethanol@ to protect against bacterial and esp. viral infections
10/15/1992	DE4111241A1 Use of deproteinised extract of young calves blood - optionally co-administered with theophylline, for treatment of sleep apnea
10/15/1992	CA2116362A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/14/1992	EP0508701A2 Probiotic
10/14/1992	EP0508672A2 Fish prolactin
10/14/1992	EP0508496A1 Methods of reconstituting lyophilized cells including reconstituting media
10/14/1992	EP0507849A1 Cool storage of cultured epithelial sheets.
10/14/1992	EP0507839A1 Method of separating haemopoietic progenitor cells.
10/14/1992	EP0348429B1 Liver lactogenic factor
10/14/1992	CN1065205A Preventive agent against infectious disease of crustacea
10/14/1992	CN1018615B Water-soluble pearl-layer powder
10/13/1992	US5154931 Bound by solid carrier to application site; treatment of periodontal disease
10/13/1992	CA1308711C Derivatives of monophosphoryl lipid a and process for preparation
10/09/1992	CA2064954A1 Probiotic
10/07/1992	EP0507555A1 Use of rapamycin for treating diabetes
10/07/1992	EP0506714A1 Matrix with adherently bound cells and process for producing viruses/virus antigens.
10/07/1992	EP0316313B1 Process for the preparation of antibiotics 10381b
10/07/1992	EP0213180B1 Neovascularization inhibitors and methods for their production and use
10/07/1992	EP0201579B1 Preparations containing a microflora having increased adhesive effect
10/07/1992	CN1065003A Medicine cap for treating eye and ear diseases
10/07/1992	CN1018523B Preparation method for pearl liquid from pearl powder
10/06/1992	US5153127 From cultivation of streptomyces or mutants thereof under aerobic conditions for controlling fungus infections in plants
10/06/1992	US5153004 Freezing and thawing of erythrocytes
10/06/1992	US5152757 System for diagnosis and treatment of wounds
10/05/1992	WO1992017203A1 Enzymatic neutralization of heparin
10/04/1992	CA2064678A1 Method of treating diabetes
10/01/1992	WO1992016600A1 Process for the extraction of peat and apparatus for carrying out the process
10/01/1992	WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
10/01/1992	WO1992016216A1 Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them
10/01/1992	DE4110217A1 Prepn. of crystalline materials for diagnosis or prevention of diseases - comprises charging body fluid in flask, injecting highly satd. steam, condensing and adding inorganic salt of oxide(s) to form suspension, filtering and crystallising

1 ... 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 ... 1259